The artificial saliva market refers to the industry that produces and supplies artificial saliva products, which are designed to provide relief and moisture to individuals suffering from dry mouth or xerostomia. A dry mouth can be caused by various factors such as medications, medical treatments, or underlying health conditions. Artificial saliva products aim to alleviate the discomfort associated with dry mouth, improve oral comfort, and reduce the risk of oral infections. The growth of the artificial saliva market is influenced by factors such as the high maintenance costs of oral health, disposable income, and per capita spending of consumers. As individuals prioritize their oral health and have the financial means to invest in such products, the market for artificial saliva is expected to expand.
According to Data Bridge Market Research, the Artificial Saliva Market is USD 1.1 billion in 2022, is expected to reach USD 3.14 billion by 2030, at a CAGR of 14% during the forecast period 2023 to 2030.
"Increasing prevalence of salivary gland disorders surge market demand"
The increasing prevalence of salivary gland disorders, including Sjögren's syndrome and radiation-induced xerostomia, is a significant driver for the artificial saliva market. These conditions cause a reduction in saliva production, leading to symptoms such as dry mouth, difficulty in swallowing, and oral health issues. As the awareness of these disorders grows and more individuals seek relief from associated symptoms, the demand for artificial saliva products is expected to rise, driving market growth in the coming years.
What restraints the growth of the artificial saliva market?
"Lack of collision detection capability can impede the market growth”
The lack of collision detection capability can impede the growth of the artificial saliva market. Collision detection refers to the ability of artificial saliva products to detect and prevent collisions with teeth or dental restorations. Without this capability, there is a risk of damage to dental work or discomfort to the user. The market growth may be hindered as consumers seek safer and more reliable options that provide effective relief for dry mouth without causing additional oral health issues. Advancements in research and development are necessary to enhance the efficacy of artificial saliva products and address the specific needs of patients with severe salivary gland dysfunction.
Segmentation: Global Artificial Saliva Market
The artificial saliva market is segmented on the basis of product, distributional channel and end users.
- On the basis of product, the artificial saliva market is segmented into oral spray, oral solution, oral liquid, dissolving tablets, gel, powder.
- On the basis of end-users, the artificial saliva market is segmented into adult, paediatric.
- On the basis of distributional channel, the artificial saliva market is segmented into supermarkets and hypermarkets, others
Regional Insights: North America dominates the Global Artificial Saliva Market
North America's dominance in the artificial saliva market can be attributed to several factors. Firstly, the region benefits from the easy availability of artificial saliva products, with a well-established distribution network and a wide range of options for patients. Secondly, North America has a significant patient population, including individuals with conditions like Sjögren's syndrome and radiation-induced xerostomia, who require artificial saliva for symptom management. The increasing demand for artificial saliva products in the region is expected to further drive market growth in North America.
The Asia-Pacific region is poised for significant growth in the artificial saliva market due to several factors. The region benefits from the easy availability of artificial saliva products, with an increasing number of manufacturers and suppliers catering to the demand. Additionally, the presence of a large patient population, including individuals with dry mouth conditions, contributes to the growing demand for artificial saliva. These factors, combined with rising awareness and improving healthcare infrastructure, are expected to drive the market's growth in Asia-Pacific.
To know more about the study, visit, https://www.databridgemarketresearch.com/reports/global-artificial-saliva-market
The Prominent Key Players Operating in the Global Artificial Saliva Market Include:
- Cipla Inc. (India)
- Mission Pharmacal Company (U.S.)
- Fresenius Kabi AG (Germany)
- Parnell Pharmaceuticals, Inc. (U.S.)
- Forward Science (U.S.)
- Laboratorios KIN S.A. (Spain)
- ICPA Health Products Ltd (India)
- NANOCHEMAZONE (U.K.)
- Lee BioSolutions (U.S.)
- Livealth (India)
- GSK Plc (U.K.)
- CCMed Group (U.K.)
- ENTOD INTERNATIONAL (India)
- Midatech Pharma Plc. (U.K.)
- Valeant Pharmaceuticals International, Inc. (Canada)
- Biocosmetics Laboratories S.L. (Spain)
- Perrigo Company plc. (Ireland)
Above are the key players covered in the report, to know about more and exhaustive list of artificial saliva market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Artificial Saliva Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by dbmr research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
